RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 17, 2016 5:46 PM ET

Archived: Nanofiber Solutions is a regenerative medicine company developing a new class of implants for soft tissue/organ repair/regeneration

iCrowdNewswire - Aug 17, 2016


Nanofiber Solutions. Inc.

Nanofiber Solutions is a regenerative medicine company developing a new class of implants for soft tissue/organ repair/regeneration.


Company Summary


Using a platform technology we combine the benefits of synthetic (man made) and biologic (cell-based) devices while eliminating the risks inherent in each. Our technology is used to build scaffolds that are critical in the development of life-saving tissue engineered implants. We manufacture the world’s first nanofiber tracheal implant. Our products have been used in successful surgeries and we are rapidly expanding our patent estate.



  • StageProduct In Development
  • IndustryMedical Devices and Equipment
  • LocationColumbus, OH, USA
  • CurrencyUSD
  • FoundedApril 2009
  • Employees9
  • Websitenanofibersolutions.com



  • Mr. Kayuha specializes in building start-up companies to maximize their market potential. His past includes a senior role during Claremont Technology Group’s growth from $3M to over $65M Revenues in six years; including an IPO and eventual acquisition. Ross was the CEO of Strategic Thinking Industries, a healthcare software start-up company, and has served as either CEO or advisor to many other start-ups.


  • Dr. Johnson has a PhD in Materials Science & Engineering from the Ohio State University with a focus on biomedical applications. As an inventor of our base technology, and with several years’ experience building bioengineered scaffolds, he is considered a leader in this emerging field. Because of his reputation, Dr. Johnson is the inventor of the first nanofiber tracheal implant, and he is regularly contacted for surgical device consultations.


  • 629367f0 b091 4884 ad4e fc68d6f6e322
    Chief Operating Officer

    Ronny has over 25 years of product development experience with eighteen years’ experience in regulated product development with C.R. Bard. In his most recent roles as VP of R&D and VP Strategic Initiatives he led identification, development and modifications to products that have achieved over $650M in cumulative Revenue. Mr. Bracken is considered an expert at developing regulated medical devices.

Contact Information:

Ross Kayuha

View Related News >